News|Videos|October 30, 2023
Optimal Workup Strategies in Advanced Endometrial Cancer
Author(s)Ritu Salani, MD, Bhavana Pothuri, MD
Explore the case of a 67-year-old patient with recurrent endometrial cancer, highlighting the importance of MMR testing, NGS, and emerging treatment options in today's landscape.
Advertisement
Episodes in this series
Advertisement
Related to this article
Dana Chase, MD, discusses why B7-H4 has emerged as a promising antibody-drug conjugate target in ovarian and endometrial cancer.
Advertisement
Advertisement
Trending on OncLive
1
Tam-Peli Reduces Risk of Death by 54% vs Topotecan in Relapsed SCLC
2
Ris-Rez Extends Median OS to 18.5 Months vs Topotecan in Relapsed SCLC
3
Iza-Bren Elicits 33% ORR, 6.9-Month PFS in Post-Osimertinib EGFR-Mutated NSCLC
4
Dr Liu on Building on the ADRIATIC Regimen in Limited-Stage Small Cell Lung Cancer
5